Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients
Status:
Recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
To compare the efficacy, as measured by time to treatment failure, of metronomic
cyclophosphamide with respect to doxorubicin in elderly patients affected by mSTS.